Citation Impact
Citing Papers
Prevalence and risk of violence against children with disabilities: a systematic review and meta-analysis of observational studies
2012 Standout
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
2017 Standout
Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach
2016
Cognition and Depression: Current Status and Future Directions
2010 Standout
Depression
2018 Standout
Converging translational evidence for the involvement of the serotonin 2A receptor gene in major depressive disorder
2014
PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1
2010 Standout
Genetic basis for individual variations in pain perception and the development of a chronic pain condition
2004 Standout
Therapeutic Applications of Selective and Non-Selective Inhibitors of Monoamine Oxidase A and B that do not Cause Significant Tyramine Potentiation
2003
The Role of the Cerebellum in Schizophrenia
2008
Diagnosis and treatment of Parkinson disease: molecules to medicine
2006
Notch signaling in development and disease
2003
Aggressive behaviour, victimisation and crime among severely mentally ill patients requiring hospitalisation
2007
Role of the 5-HT2A receptor in the locomotor hyperactivity produced by phenylalkylamine hallucinogens in mice
2013
Arrestin Development: Emerging Roles for β-arrestins in Developmental Signaling Pathways
2009 StandoutNobel
Psychedelics
2016 Standout
The neuronal insulin sensitizer dicholine succinate reduces stress-induced depressive traits and memory deficit: possible role of insulin-like growth factor 2
2012
A review and re‐evaluation of an association between the NOTCH4 locus and schizophrenia
2006
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Brain-Derived Neurotrophic Factor Val66Met and Psychiatric Disorders: Meta-Analysis of Case-Control Studies Confirm Association to Substance-Related Disorders, Eating Disorders, and Schizophrenia
2007
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Pathophysiological distortions in time perception and timed performance
2011 Standout
Brain-derived neurotrophic factor and risk of schizophrenia: An association study and meta-analysis
2006
Pharmacogenetics of Antidepressants
2011
Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response
2004
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
2004 Standout
The Catechol-O-Methyltransferase Polymorphism: Relations to the Tonic–Phasic Dopamine Hypothesis and Neuropsychiatric Phenotypes
2004
A dopamine D2 receptor gene-related polymorphism is associated with schizophrenia in a Spanish population isolate
2007
β-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO)
2009 Standout
Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia
2007
Levodopa/carbidopa/entacapone in Parkinson’s disease
2009
Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcome
2009
The variable nature of cognitive control: a dual mechanisms framework
2012 Standout
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
The molecular neurobiology of depression
2008 StandoutNature
Clinical Pharmacology, Therapeutic Use and Potential of COMT Inhibitors in Parkinson???s Disease
2000
The neurobiology of depression and antidepressant action
2012
Magnesium in Man: Implications for Health and Disease
2014 Standout
The Genetics of Mood Disorders
2009
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Gut microbiota are related to Parkinson's disease and clinical phenotype
2014 Standout
Catechol-O-methyltransferase (COMT): Biochemistry, Molecular Biology, Pharmacology, and Clinical Efficacy of the New Selective COMT Inhibitors
1999
Clinical pharmacology and therapeutic use of COMT inhibition in Parkinson's disease
2007
Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder
2008 Standout
Works of Ari Illi being referenced
TPH1 218A/C polymorphism is associated with major depressive disorder and its treatment response
2009
Association between 5-HT2A, TPH1 and GNB3 genotypes and response to typical neuroleptics: a serotonergic approach
2007
Vascular endothelial growth factor (VEGF) polymorphism is associated with treatment resistant depression
2010
5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression
2009
Interaction between two HTR2A polymorphisms and gender is associated with treatment response in MDD
2011
Interaction between angiotensin-converting enzyme and catechol-O-methyltransferase genotypes in schizophrenics with poor response to conventional neuroleptics
2003
Dopamine receptor D2 −141C Insertion/Deletion polymorphism in a Finnish population with schizophrenia
2003
The effect of entacapone on the disposition and hemodynamic effects of intravenous isoproterenol and epinephrine*
1995
Simultaneous inhibition of catechol-O-methyltransferase and monoamine oxidase A: Effects on hemodynamics and catecholamine metabolism in healthy volunteers*
1996
Simultaneous inhibition of catecholamine- O -methylation by entacapone and neuronal uptake by imipramine: lack of interactions
1996
Catechol-O-methyltransferase and Monoamine Oxidase A Genotypes and Drug Response to Conventional Neuroleptics in Schizophrenia
2003
NOTCH4 gene promoter polymorphism is associated with the age of onset in schizophrenia
2003
Interaction between NOTCH4 and catechol-O-methyltransferase genotypes in schizophrenia patients with poor response to typical neuroleptics
2004
The effects of the COMT inhibitor entacapone on haemodynamics and peripheral catecholamine metabolism during exercise
1993
Is 5-HTTLPR linked to the response of selective serotonin reuptake inhibitors in MDD?
2010
Neuregulin genotype and medication response in Finnish patients with schizophrenia
2004
Lack of association between two polymorphisms of brain-derived neurotrophic factor and response to typical neuroleptics
2004
Association of EGF polymorphism with schizophrenia in Finnish men
2004
COMT inhibition by high-dose entacapone does not affect hemodynamics but changes catecholamine metabolism in healthy volunteers at rest and during exercise.
1994
2003
Effect of entacapone, a COMT inhibitor, on the pharmacokinetics of levodopa and on cardiovascular responses in patients with Parkinson's disease
1993